E3 Ubiquitin Ligase in Anticancer Drugdsla Resistance: Recent Advances and Future Potential

E3 Ubiquitin Ligase in Anticancer Drugdsla Resistance: Recent Advances and Future Potential

Drug therapy is the primary treatment for patients with advanced cancer. The use of anticancer drugs will inevitably lead to drug resistance, which manifests as tumor recurrence. Overcoming chemoresistance may enable cancer patients to have better therapeutic effects. However, the mechanisms underly...

Full description

Bibliographic Details
Main Authors: Yuanqi Liu, Chaojun Duan, Chunfang Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
E3 ubiquitin ligase
cancer
cancer treatment
drugresistance
drug
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.645864/full

Similar Items

Similar Items